Stem cell therapies to treat muscular dystrophy: progress to date

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Mirella MeregalliYvan Torrente

Abstract

Muscular dystrophies are heritable, heterogeneous neuromuscular disorders and include Duchenne and Becker muscular dystrophies (DMD and BMD, respectively). DMD patients exhibit progressive muscle weakness and atrophy followed by exhaustion of muscular regenerative capacity, fibrosis, and eventually disruption of the muscle tissue architecture. In-frame mutations in the dystrophin gene lead to expression of a partially functional protein, resulting in the milder BMD. No effective therapies are available at present. Cell-based therapies have been attempted in an effort to promote muscle regeneration, with the hope that the host cells would repopulate the muscle and improve muscle function and pathology. Injection of adult myoblasts has led to the development of new muscle fibers, but several limitations have been identified, such as poor cell survival and limited migratory ability. As an alternative to myoblasts, stem cells were considered preferable for therapeutic applications because of their capacity for self-renewal and differentiation potential. In recent years, encouraging results have been obtained with adult stem cells to treat human diseases such as leukemia, Parkinson's disease, stroke, and muscular dystrophies. Embryo...Continue Reading

References

Sep 1, 1991·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·A I Caplan
Feb 1, 1996·Muscle & Nerve·J E MorganT A Partridge
Mar 7, 1996·Nature·K H CampbellI Wilmut
Jun 4, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M J DohertyA E Canfield
Nov 11, 1998·Nature Medicine·T PartridgeE Hoffman
Feb 4, 1999·Nature Medicine·G Keller, H R Snodgrass
Apr 2, 1999·Science·M F PittengerD R Marshak
Jun 29, 2001·Nature·G FerrariF Mavilio
Sep 5, 2001·Nature Cell Biology·J G TomaF D Miller
Mar 7, 2002·Lancet·Alan E H Emery
Apr 23, 2002·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Miranda D GroundsMarie A Bogoyevitch
May 22, 2002·The Journal of Cell Biology·Zhuqing Qu-PetersenJohnny Huard
Jun 22, 2002·Nature·Yuehua JiangCatherine M Verfaillie
Aug 6, 2002·Experimental Hematology·Yuehua JiangCatherine M Verfaillie
Oct 11, 2002·Nature·I WilmutL E Young
Nov 9, 2002·Experimental Hematology·Atsushi Asakura, Michael A Rudnicki
Jan 17, 2003·Stem Cells·Kathy E MitchellSatish Medicetty
Mar 28, 2003·Human Reproduction·Guido de Wert, Christine Mummery
May 22, 2003·Cell·Valerie HorsleyGrace K Pavlath
Sep 5, 2003·Nature·Erika Check
Sep 26, 2003·The American Journal of Pathology·Ken KataokaNam-Ho Huh
Oct 11, 2003·Current Opinion in Genetics & Development·Giulio Cossu, Paolo Bianco
Jan 13, 2004·Physiological Reviews·Sophie B P Chargé, Michael A Rudnicki
Jan 28, 2004·The Journal of Cell Biology·Roberta PalumboMarco E Bianchi
Mar 25, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Daniel SkukJacques P Tremblay
Aug 28, 2004·Journal of Cell Science·Enrico TagliaficoStefano Ferrari
Nov 6, 2004·Science·Aurélie GoyenvalleOlivier Danos
Jun 11, 2005·Biochemical and Biophysical Research Communications·Satyakam Bhagavati, Weimin Xu

❮ Previous
Next ❯

Citations

Mar 12, 2013·Expert Opinion on Drug Discovery·Catherine Moorwood, Tejvir S Khurana
Dec 17, 2011·Seminars in Pediatric Neurology·Carina Wallgren-PetterssonNigel G Laing
Dec 6, 2011·Biotechnology Advances·Fa-Ming ChenSongtao Shi
Mar 15, 2011·Medicina clínica·Patricia GálvezBeatriz Clares
Aug 22, 2014·Pathology International·Eun-Joo LeeKyu-Shik Jeong
Mar 13, 2015·Medicinal Research Reviews·Claudio Cabello-VerrugioFelipe Simon
Jan 1, 2013·Translation·Atossa ShaltoukiCrystal M Weyman
Sep 10, 2016·Matrix Biology : Journal of the International Society for Matrix Biology·Alexander NyströmTobias Kühl
Jun 22, 2018·Current Treatment Options in Neurology·Ava Y Lin, Leo H Wang
Apr 24, 2019·Clinical Transplantation·Jing Hu, Jimei Wang
Mar 8, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Sara VianelloSabine de la Porte
Nov 18, 2016·Journal of Neuromuscular Diseases·Merryl RodriguesToshifumi Yokota
Mar 23, 2018·ACS Applied Nano Materials·Jeanne E LemasterJesse V Jokerst

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Related Papers

Journal of Cellular and Molecular Medicine
Dorothee KlumppJustus P Beier
Journal of Tissue Engineering and Regenerative Medicine
Merel KoningPaul M N Werker
Annals of the New York Academy of Sciences
Paul R SanbergNagwa S El-Badri
© 2021 Meta ULC. All rights reserved